在国内市场，公司实现了国内一线晶圆代工厂和存储IDM厂大多数主流量产工艺平台的正片供货，已成 为国内主流存储IDM厂商全球12英寸硅片厂商中供货量第一或第二大的供应商，同时也是国内一线逻辑 晶圆代工厂中国大陆12英寸硅片供应商中供货量第一的供应商及目前国内新建12英寸晶圆厂的首选硅片 供应商之一。 来源：环球网 【环球网财经综合报道】10月22日，西安奕材（688783.SH）正式公布发行结果。本次发行价格为8.62 元/股，发行数量为53,780.00万股，全部为公开发行新股，无老股转让，募集资金总额为46.36亿元，将 全部用于西安奕斯伟硅产业基地二期项目。 作为国内12英寸硅片领域头部企业，西安奕材此次上市不仅标志着资本市场半导体材料领域再添新星， 更以"科创板八条"发布后受理并通过审核的首家未盈利企业的身份，为硬科技企业融资树立了新标杆。 西安奕材专注于12英寸硅片的研发、生产和销售，2024年月均出货量和产能规模全球占比约为6%和 7%。凭借领先的技术实力，公司已从全球12英寸硅片市场的"新进入者"快速成长为"赶超者"，在国内 外市场均建立起竞争优势。 本次上市，西安奕材募集资金将全部用于保障第二工 ...

Group 1 - The core viewpoint of the article highlights the approval of He Yuan Bio's registration application by the China Securities Regulatory Commission (CSRC), marking it as the first company to fully navigate the review process under the newly restarted fifth listing standard of the Sci-Tech Innovation Board [1] - The approval process for He Yuan Bio took just over ten working days, indicating a shift towards a more inclusive and efficient regulatory approval mechanism [1] - Other companies in the IPO queue under the fifth standard include Bei Xin Life, Si Zhe Rui, Heng Run Da Sheng, and Bi Bei Te, all from the pharmaceutical sector, which are unprofitable but possess core technologies [1] Group 2 - The fifth listing standard has been a crucial pathway for unprofitable hard-tech companies to access the capital market since the establishment of the Sci-Tech Innovation Board, particularly benefiting complex product technology firms with significant funding needs and long R&D cycles [2] - A total of 20 pharmaceutical companies have successfully listed under this standard, and it has now expanded to include more cutting-edge technology fields such as artificial intelligence, commercial aerospace, and low-altitude economy, facilitating easier financing for these hard-tech enterprises [2] - The acceleration of the review process is not about lowering standards but rather about reforming the system to allow truly impactful companies with significant market influence and technological achievements to list without being hindered by their unprofitability [2]